Pure Global

Post bone-marrow transplant engraftment study IVD, kit, nucleic acid technique (NAT) - UK MHRA Medical Device Registration

Post bone-marrow transplant engraftment study IVD, kit, nucleic acid technique (NAT) is a medical device registered with the UK's Medicines and Healthcare products Regulatory Agency (MHRA) under Device ID 156023. The device is manufactured by CareDx Pty Ltd from Australia, classified as In Vitro Diagnostic Device. The authorized representative in the UK is Qarad UK Ltd..

This page provides comprehensive regulatory information including complete registration details, manufacturer information, device classification, authorized representative details, and related products. Pure Global AI offers free access to 150,962+ UK MHRA medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
MHRA Registered
In Vitro Diagnostic Device
๐Ÿ‡ฌ๐Ÿ‡ง
Post bone-marrow transplant engraftment study IVD, kit, nucleic acid technique (NAT)
MHRA Device ID: 156023โ€ขRef: 156023

Device Type

In Vitro Diagnostic Device

Devices

Post bone-marrow transplant engraftment study IVD, kit, nucleic acid technique (NAT)

Type

IVD General

Date Registered

Nov 26, 2024

Last Updated

Jul 2, 2024

Manufacturer Information

Address

20 Collie Street

Fremantle, Australia

Created Date

Aug 27, 2021

Authorized Representative

Relationship Type

UK Responsible Person

Address

8 Northumberland Ave

Westminster, London , England, United Kingdom

Postcode: WC2N 5BY

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing